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Abstract The purpose of this investigation was to determine
the clinical and corneal microbial profile of infectious keratitis
in a high human immunodeficiency virus (HIV) prevalence
setting in rural South Africa. Data in this cross-sectional study
were collected from patients presenting with symptoms of
infectious keratitis (n=46) at the ophthalmology outpatient
department of three hospitals in rural South Africa. Corneal
swabs were tested for herpes simplex virus type 1 (HSV-1)
and 2 (HSV-2), varicella zoster virus (VZV) and adenovirus
DNA by real-time polymerase chain reaction (PCR) and for
bacteria and fungi by culture. Based on clinical history, dis-
ease characteristics and laboratory results, 29 (63 %) patients
were diagnosed as viral keratitis, including 14 (48 %) viral
keratitis cases complicated by bacterial superinfection, and
17 (37 %) as bacterial keratitis. VZV and HSV-1 DNA was
detected in 11 (24 %) and 5 (11 %) corneal swabs, respective-
ly. Among clinically defined viral keratitis cases, a negative
viral swab was predominantly (93 %) observed in cases with
subepithelial inflammation and was significantly associated
with an increased duration of symptoms (p=0.003). The ma-
jority of bacteria cultured were Gram-positive (24/35), includ-
ing Staphylococcus epidermidis and S. aureus. Viral aetiology
was significantly associated with a history of herpes zoster
ophthalmicus (p<0.001) and a trend was observed between
viral aetiology and HIV infection (p= 0.06). Twenty-one
(47 %) keratitis cases were complicated by anterior uveitis,
of which 18 (86 %) were HIV-infected cases with viral kera-
titis. The data implicate a high prevalence of herpetic keratitis,
in part complicated by bacterial superinfection and/or uveitis,
in HIV-infected individuals presenting with infectious kerati-
tis in rural South Africa.
Introduction
Infectious keratitis is a major cause of ocular morbidity world-
wide and the most common cause of unilateral corneal blind-
ness in low-resource settings [1]. The estimated population
incidence of infectious keratitis in these settings is up to 800
per 100,000/year, which is about 70 times higher than in high-
resource settings [1]. Early diagnosis is essential, as visual
outcome depends on the prompt initiation of targeted antimi-
crobial treatment [2, 3]. The spectrum of keratitis-associated
pathogens is diverse and includes viruses, bacteria, fungi and
protozoa. Moreover, the clinical picture and aetiology of in-
fectious keratitis varies geographically, as it is subject to both
environmental and host factors [1, 2].
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Viruses, in particular human alpha herpesviruses, are well
known inWestern countries for causing recurrent and devastat-
ing keratitis, but data from sub-Saharan African countries are
scarce and solely based on clinical diagnosis [4–6]. The high
human immunodeficiency virus (HIV) prevalence in this region
may play an important role in the distribution of keratitis-
associated pathogens, as HIV-infected individuals are at higher
risk for viral keratitis, particularly varicella zoster virus (VZV)
keratitis [7]. However, themanagement of infectious keratitis in
this region predominantly involves (presumptive) antibiotic
and/or anti-fungal treatment, which may lead to inappropriate
treatment of patients with viral keratitis, thereby increasing the
risk of visual disability [8]. Elucidation of both the aetiology of
infectious keratitis, in particular the potential role of viruses,
and the associated clinical picture in a high HIV prevalence
setting such as rural South Africa is of paramount importance
to improve diagnosis and clinical management aimed to pre-
vent visual impairment and blindness.
The aim of the current study was to determine the clinical
and corneal microbial profile of infectious keratitis in a high
HIV prevalence setting in rural South Africa.
Materials and methods
Study population and setting
This cross-sectional study was conducted at the ophthalmology
outpatient department of three hospitals in rural South Africa
(Mopani District) between September 2013 and May 2015.
Criteria for participation were adult age (≥18 years old), no
recent history of ocular surgery or trauma, willingness to test
for HIV and a clinical diagnosis of keratitis based on slit-lamp
examination: inflammation of the cornea with or without the
presence of a corneal epithelial defect [2, 3, 9]. Contact lens
wearers were excluded. Infectious keratitis was classified as
viral, bacterial, fungal and/or protozoan on the basis of clinical
history (e.g. history of unilateral painful skin rash in the derma-
tomal distribution of the trigeminal nerve as a sign of VZV
infection), disease characteristics (e.g. typical herpetic corneal
dendrites, disciform keratitis or an epithelial defect associated
with a larger infiltrate as a sign of bacterial keratitis), laboratory
results and response to initiated treatment according to current
diagnostic criteria [3, 10, 11]. Infectious keratitis patients pre-
senting with uveitis were defined as keratouveitis. Treatment of
infectious keratitis was initiated according to standard treatment
guidelines for hospitals from the National Department of
Health of South Africa [12]. Ethical clearance for this study
was obtained from the Human Research Ethics Committee
(University of the Witwatersrand, Johannesburg, South
Africa; project ID: M130201). Written informed consent was
obtained from all participants.
Ophthalmic examination
Demographic and clinical data were collected using a ques-
tionnaire and full ophthalmic examination was performed,
including visual acuity using an ‘Illiterate E’ Snellen chart at
a distance of 6 m, slit-lamp examination, intraocular pressure
using the Icare TA01i (Icare Finland Oy, Helsinki, Finland)
and dilated indirect funduscopy. Visual acuity after treatment
was also determined at routine clinical follow-up visits. Visual
impairment was defined according to the International
Classification of Diseases on the basis of the individual’s vi-
sual acuity [13]. Counselling and HIV testing following rou-
tine practice were performed for all participants who reported
to be HIV-uninfected or were unaware of their HIV status.
Diagnostic CD4 counts were determined in all HIV-infected
participants.
Laboratory analyses
Corneal samples were collected from the affected eye under
topical anaesthesia using a corneal swab and an eyelid spread-
er to prevent contamination from the eyelids. Due to the lack
of ophthalmological care in this region, we chose to perform
corneal swabbing instead of corneal scraping, as complica-
tions due to corneal swabbing are less likely to occur. All
samples were collected by the same investigator (ES). First,
a corneal swab for virus detection was obtained in 5 mL col-
lection medium (Puritan Diagnostics, Guilford, CT, USA).
Viral swabs were examined for herpes simplex virus type 1
(HSV-1), HSV type 2 (HSV-2), VZVand adenovirus DNA by
real-time polymerase chain reaction (PCR) using virus-
specific primer/probe combinations at the diagnostic laborato-
ry of the Department of Viroscience of Erasmus Medical
Center (Rotterdam, the Netherlands), as described elsewhere
[14]. The sensitivity of the virus-specific real-time PCR as-
says, as defined by the 95 % hit rate on the electron micros-
copy counted virus stocks, was about 100 virus genome-
equivalent copies/mL. A second swab (Transystem™) for
bacterial and fungal culture (Copan Diagnostics Inc.,
Murrieta, CA, USA) was obtained from the same eye.
Microbial examination, including Gram stain microscopy
and culture, was performed on swabs for bacteria and fungi
at the Lancet Laboratory according to standard diagnostic
procedures (Tzaneen, South Africa).
Statistical analysis
Data were double-entered into Epi Info version 3.5.4 [Centers
for Disease Control and Prevention (CDC), Atlanta, GA,
USA] and analysed using IBM SPSS Statistics version 22
(IBM, New York City, NY, USA). Descriptions of the study
population and clinical and laboratory findings were per-
formed using number with proportion and median with
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interquartile range (IQR) and stratified to HIV status.
Demographic, clinical and laboratory factors were compared
between different aetiologies of keratitis to identify factors
associated with infectious keratitis. Comparison was done by
Chi-squared tests with Fisher’s exact test if appropriate for
categorical variables and the Mann–Whitney test for continu-
ous variables. Data are presented as an odds ratio (OR) with
95 % confidence interval (CI) or as a median with IQR.
Results
Demographics and clinical presentation
We recruited 46 patients clinically diagnosed with infectious
keratitis, consisting of 29 (63 %) women and 17 (37 %) men,
with a median age of 41 (IQR 31–59) years (Table 1). Twenty-
eight (61 %) participants were HIV-infected, of which 6
(21 %) were tested reactive to HIV for the first time and 13
(46 %) were on antiretroviral therapy (ART). The median
CD4 count at enrolment was 226 (IQR 156–329) CD4 T-
cells/mm3 for those on ART and 299 (IQR 160–396) CD4
T-cells/mm3 for ART-naïve participants.
Reduced vision was the most common complaint reported
at enrolment (100 %), followed by eye pain (96 %), tearing
(72 %) and photophobia (65 %). The median duration of
symptoms was 19 (IQR 11–38) days. Twenty-six (57 %)
patients had been referred from a primary healthcare (PHC)
facility. Fourteen (30 %) patients reported the use of topical
antibiotic eye ointment (Chloramphenicol) prior to inclusion;
unfortunately, only three patients (21 %) used the ointment
adequately. At ophthalmic examination, an epithelial defect
was the most commonly observed clinical characteristic
(65 %), followed by signs of anterior chamber inflammation
(52 %). Corneal infiltration was the most common clinical
characteristic associated with an epithelial defect (33 %),
followed by corneal dendrites (27 %), punctate epithelial ker-
atitis (20 %) and corneal ulceration (20 %). In cases of
subepithelial inflammation, stromal keratitis was the most of-
ten observed clinical characteristic (56 %), followed by
subepithelial infiltration (31 %) and endothelial inflammation
(13 %). An intraocular pressure >21 mmHg was observed in 9
of 43 (21 %) patients.
Microbial laboratory analyses on corneal swabs
Viral DNA was detected from corneal swabs in 16 of 45
(36 %) patients; one viral corneal swab was unavailable for
viral diagnostics. Whereas HSV-2 and adenovirus DNA was
undetectable by PCR, 11 (24 %) and 5 (11 %) swabs were
positive for VZV [median PCR cycle threshold (Ct) value of
37.0 (IQR 32.2–38.9)] and HSV-1 [median PCR Ct value of
33.0 (IQR 26.6–36.7)] DNA, respectively (Table 2). Bacteria
were cultured from the corneal swabs of 29 (63 %) patients,
Table 1 Characteristics of infectious keratitis patients enrolled in this study
HIV infected (n= 28) HIV uninfected (n= 18) Crude odds ratio (95 % CI) p-Value
Gender
Female 22 (76) 7 (24) 5.8 (1.6–21.3) 0.01
Male 6 (35) 11 (65)
Age in years 38 (31–45) 52 (27–72) na 0.19
Ethnicity
Sotho 19 (66) 10 (34) 1.7 (0.5–5.7) 0.53
Shangaan 9 (53) 8 (47)
Low educational status 10 (36) 9 (50) 0.6 (0.2–1.9) 0.37
Low financial income 22 (79) 14 (78) 1.0 (0.3–4.4) 1.00
CD4 cell count in cells/mm3 254 (162–353) na na na
Days between onset of eye complaints and presentation 18 (11–49) 23 (9–38) na 0.93
Referred from primary healthcare facility 18 (64) 8 (44) 2.3 (0.7–7.5) 0.23
Use of topical antibiotics prior to enrolment 10 (36) 4 (22) 1.9 (0.5–7.5) 0.51
Diagnosis (clinical and laboratory data combined)
Viral keratitis (n= 15) 10 (67) 5 (33) 3.7 (1.1–13.3)a 0.06
Viral and bacterial keratitis (n = 14) 11 (79) 3 (21)
Bacterial keratitis (n= 17) 7 (41) 10 (59)
Data are shown as number (%) or median (interquartile range)
CI confidence interval; p-Value Pearson Chi-square or Mann–Whitney U test; na not applicable; HIV human immunodeficiency virus
a Crude odds ratio and p-values were calculated for viral keratitis (including viral and bacterial keratitis) vs. bacterial keratitis
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mainly Gram-positive bacteria (69 %) with Staphylococcus
epidermidis as the most common detected bacterium (36 %),
followed by S. aureus (14 %) and S. capitis (9 %). Based on
clinical history, disease characteristics, laboratory results and
response to initiated treatment (i.e. antibiotics or antiviral), 29
(63 %) patients were diagnosed as viral keratitis, including 14
(48 %) viral keratitis cases complicated by bacterial superin-
fection and 17 (37 %) as bacterial keratitis (Table 2).
Among patients diagnosed with viral keratitis, 15 (52 %)
corneal swabs were positive for viral DNA and 14 (48 %)
were negative. Positive viral swabs were predominantly ob-
tained from cases with epithelial inflammation (67 %), with
dendritic corneal lesions (70 %) as the most common epithe-
lial inflammation, followed by geographic ulcers (20 %).
Negative viral swabs were predominantly obtained from cases
with subepithelial inflammation (13 of 14, 93 %). Only in one
(7 %) case with an epithelial inflammation, presenting with a
dendritic lesion typical for HSV-1 epithelial keratitis, could no
viral DNA be detected. Notably, subepithelial inflammation
was significantly associated with higher median PCR Ct
Table 2 Aetiology of infectious keratitis defined by clinical and laboratory diagnostic methods
HSV-1 PCRPOS VZV PCRPOS Microbial culture positive
HIV-infected patients (n= 28)
Viral keratitis (n= 10)
Laboratory-confirmed diagnosis (n= 4) n= 2 n = 2 No bacterium cultured
Clinical diagnosis only (n= 6) None None No bacterium cultured
Viral and bacterial keratitis (n= 11)
Laboratory-confirmed diagnosis (n= 8) n= 1 n = 7 Staphylococcus epidermidis (n= 3)
Staphylococcus aureus (n= 2a)
Bacillus species (n = 1)
Stenotrophomonas maltophilia (n = 1)
Staphylococcus epidermidis and Escherichia coli (n= 1)
Clinical diagnosis only (n= 3) None None Staphylococcus capitis (n= 1)
Staphylococcus epidermidis (n= 1)
Enterobacter cloacae (n= 1)
Bacterial keratitis (n = 7)b
Laboratory-confirmed diagnosis (n= 7) None None Staphylococcus epidermidis (n= 2)
Pseudomonas aeruginosa (n= 2)
Staphylococcus capitis (n= 1)
Staphylococcus aureus and Streptococcus viridans (n= 1)
Corynebacterium, Enterococcus faecalis, Escherichia coli
and Candida albicans (n= 1)
Clinical diagnosis only (n= 0) None None No bacterium cultured
HIV-uninfected patients (n = 18)
Viral keratitis (n= 5)
Laboratory-confirmed diagnosis (n= 2) n= 2 None No bacterium cultured
Clinical diagnosis only (n= 3) None None No bacterium cultured
Viral and bacterial keratitis (n= 3)
Laboratory-confirmed diagnosis (n= 1) None n = 1 Staphylococcus aureus and Proteus mirabilis (n = 1)
Clinical diagnosis only (n= 2) None None Staphylococcus epidermidis (n= 1)
Staphylococcus capitis and Acinetobacter haemolyticus (n= 1)
Bacterial keratitis (n = 10)
Laboratory confirmed diagnosis (n= 8) None n = 1c Staphylococcus epidermidis (n= 4)
Staphylococcus aureus (n= 1)
Pseudomonas aeruginosa (n= 1)
Staphylococcus epidermidis and Proteus mirabilis (n = 1)
Streptococcus viridans and Haemophilus influenza (n= 1)
Clinical diagnosis only (n= 2) None None No growth in culture (n= 2)
HIV human immunodeficiency virus; HSV-1 herpes simplex virus type 1; VZV varicella zoster virus
a HSV-1 DNAwas detected in combination with Staphylococcus aureus
b One viral corneal swab was unavailable after transport
c Vascular leakage of VZV DNA from extensive corneal neovascularisation most likely resulted in the detection of VZV DNA
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values [median of 38.2 (IQR 37.4–39.1) for subepithelial in-
flammation vs. 32.6 (IQR 26.7–35.0) for epithelial inflamma-
tion, p=0.005]. Furthermore, viral DNA-negative swabs were
significantly associated with an increased duration of symp-
toms [median of 37 (IQR 23–92) days for cases with DNA-
negative swabs vs. 14 (IQR 6–18) days for cases with DNA-
positive swabs, p=0.003]. A reported history of herpes zoster
ophthalmicus (OR=46.9, 95 % CI 7.4–287.6; p<0.001) was
associated with a viral aetiology of keratitis and a trend be-
tween viral aetiology and HIV infection (OR=3.7, 95 % CI
1.1–13.3; p=0.06) was also observed. Among viral keratitis
cases, a bacterial superinfection was associated with lower
CD4 cell counts [median of 168 (IQR 92–322) cells/mm3
for viral keratitis with bacterial superinfection vs. 312 (IQR
212–490) cells/mm3 for viral keratitis, p<0.05].
Twenty-one (47 %) keratitis cases were complicated by
anterior uveitis, of which 18 (86 %) were viral keratitis.
Viral DNA was detected in the corneal swabs of 11 of 18
(61 %) keratouveitis patients: VZV (n = 10) and HSV-1
(n=1) (Table 3). Keratouveitis cases were significantly more
common among HIV-infected than HIV-uninfected individ-
uals (OR=16.9, 95% CI 3.2–89.7; p<0.001), among patients
with an intraocular pressure of >21 mmHg than ≤21 mmHg
(OR=5.0, 95 % CI 0.9–27.7; p=0.05) and among viral than
bacterial aetiology (OR=7.6, 95 % CI 1.8–32.7; p=0.005).
Also, a trend between lower CD4 cell counts and uveitis was
observed among those with HIV infection [median of 226
(IQR 137–332) cells/mm3 for keratouveitis vs. 343 (IQR
194–427) cells/mm3 for keratitis, p=0.09].
Clinical outcome of disease
Follow-up after treatment initiation was poor. Thirty-four of
46 (74 %) patients had one or more follow-up visits and the
median follow-up time was 7 (IQR 7–28) days. The affected
eye was visually impaired at the last follow-up visit after treat-
ment initiation in 17 of 34 (50 %) patients, of which 8 (47 %)
were blind. Severe visual impairment and blindness was sig-
nificantly associated with increased duration of symptoms
[median of 36 (IQR 20–112) days for severe visual impair-
ment and blindness vs. 14 (IQR 6–37) days for no severe
visual impairment and blindness, p=0.02]. Adjusting for du-
ration of symptoms, no demographic or clinical characteristics
were associated with severe visual impairment and blindness
(data not shown). Notably, a bacterial superinfection in viral
keratitis patients was not associated with poorer outcome after
treatment.
Discussion
This study reports on the clinical and corneal microbial profile
of infectious keratitis in patients presenting to the ophthalmol-
ogy outpatient department of three hospitals in a high HIV
prevalence setting in rural South Africa. The data implicate
that corneal herpesvirus infections, in part complicated by
bacterial superinfection and/or uveitis, are relatively more fre-
quently associated with infectious keratitis in HIV-infected
individuals with pronounced visual morbidity. A significant
Table 3 Factors associated with the development of uveitis in infectious keratitis patients
Uveitis present (n= 21) Uveitis absent (n= 25) Crude odds ratio (95 % CI) p-Value
Gender
Female 16 (55) 13 (45) 3.0 (0.8–10.6) 0.13
Male 5 (30) 12 (70)
Age in years 38 (32–49) 41 (30–62) na 0.68
Low educational status 10 (53) 9 (47) 1.6 (0.5–5.3) 0.55
Low financial income 18 (86) 18 (72) 2.3 (0.5–10.5) 0.26
HIV infected 19 (91) 9 (36) 16.9 (3.2–89.7) <0.001
CD4 cell count in cells/mm3 226 (137–332) 343 (194–427) na 0.09
Days between onset of eye complaints and 18 (11–45) 24 (9–39) na 0.97
Intraocular pressure of >21 mmHg presentation 7 (33) 2 (9)a 5.0 (0.9–27.7) 0.05
Diagnosis (clinical and laboratory data combined)
Viral keratitis (n= 15) 7 (47) 8 (53) 7.6 (1.8–32.7)b 0.005
Viral and bacterial keratitis (n = 14) 11 (79) 3 (24)
Bacterial keratitis (n= 17) 3 (18) 14 (82)
Data are shown as number (%) or median (interquartile range)
CI confidence interval; p-Value Pearson Chi-square or Mann–Whitney U test; na not applicable; HIV human immunodeficiency virus
a Three keratitis patients without uveitis had no recorded intraocular pressure
b Crude odds ratio and p-value were calculated for viral keratitis (including viral and bacterial keratitis) vs. bacterial keratitis
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association between HIV infection and keratouveitis was not-
ed, suggesting its potential use as a clinical marker to prompt
investigation of the patient’s HIV status.
The observed high frequency of viral aetiology of infectious
keratitis in our study has not been described before in sub-
Saharan Africa and is higher than observations in similar stud-
ies from Australia and China [2, 15]. The major role of herpes-
viruses might be due to the high HIV prevalence, because a
trend was observed between HIV infection and viral keratitis.
Our data are in line with observations reporting increased sus-
ceptibility of HIV-infected individuals to viral keratitis [7]. We
identified VZV as the most prevalent viral cause of infectious
keratitis in our study population. This contrasts previous studies
from sub-Saharan Africa and high-resource countries that re-
port a predominant role of HSV-1 causing viral keratitis [5, 6,
16]. The important role of VZVin our studymight be due to the
high HIV prevalence, as HIV-infected individuals are at higher
risk for VZV keratitis than for HSV-1 keratitis [7, 17].
Unfortunately, previous studies from sub-Saharan Africa did
not report on the patients’ HIV status [5, 6]. Reasons for the
observed minor role of HSV-1 in our study remain unclear, as
seroprevalence of HSV-1 among HIV-infected ART-naïve in-
dividuals in our setting is very high (98 %) [18]. Adenovirus
was not detected in our study, which contrasts earlier studies
performed in high-resource settings where adenovirus is iden-
tified as an important causative pathogen of keratoconjunctivi-
tis [19]. Studies from sub-Saharan Africa are not available, but
our results may suggest that geographical factors play a role in
the different pathogen distribution observed.
The distribution of bacterial pathogens, largely Gram-
positive bacteria, confirms observations in other studies from
sub-Saharan Africa [8, 20]. Bacteria were detected in almost
half of the viral keratitis cases and bacterial superinfection was
associated with lower CD4 cell count. Although limited data
are available on the clinical consequences of bacterial super-
infections in viral keratitis, bacterial superinfections may
worsen the visual outcome of HSV keratitis if appropriate
treatment is delayed [21]. In our study, however, poorer visual
outcome after treatment was not associated with bacterial su-
perinfection. A fungus (Candida albicans) was detected in
only one patient diagnosed with bacterial keratitis. This is in
sharp contrast to similar studies fromGhana and Tanzania that
reported fungi as the causative pathogen in up to 50 % of
keratitis cases [22, 23]. This may be due to the exclusion of
traumatic keratitis, as trauma is one of the most important risk
factors for fungal keratitis, or due to the geographical differ-
ences, as fungal keratitis is more likely to occur toward trop-
ical latitudes [2, 3].
PCR analyses of corneal swabs supported the clinical obser-
vation of viral keratitis in cases with epithelial inflammation. In
cases with subepithelial inflammation, however, the detection of
viral DNA was often negative and, if positive, just above the
detection limit of the qPCR. This is in line with a study that
observed a lower percentage of keratitis cases with positive
HSV-1 DNA in patients with subepithelial inflammation com-
pared to patients with epithelial inflammation [24]. Furthermore,
increased disease duration was associated with a negative viral
swab in cases with a clinical viral keratitis diagnosis.
Anterior uveitis was an important complication of infec-
tious keratitis in our study, in particular in cases of viral
aetiology and among HIV-infected individuals. This poses a
challenge, as the management of keratouveitis requires
specialised treatment. The association between HIV infection
and the development of anterior uveitis, combined with the
observed trend between immunodeficiency and anterior uve-
itis, suggest that cell-mediated immunity plays an important
role in controlling corneal infection [25, 26]. Also, the pres-
ence of anterior uveitis might be used as a pointer of HIV
infection that indicates the need for HIV counselling and test-
ing in patients presenting with this condition.
The visual outcome at the last follow-up visit after treat-
ment of infectious keratitis observed in our study was poor
and associated with increased duration of symptoms, which
confirms observations from a study from Tanzania addressing
visual outcome in infectious keratitis [8]. Unfortunately, we
did not collect data to determine the reasons for this delay, but
both patient- and healthcare system-associated factors may
have played a role. A potential contributing factor to the poor
visual outcome observed is initial mismanagement at the PHC
level, as none of the referred patients from PHC facilities
received topical antiviral and/or adequate antibiotic treatment.
A limitation to this study is the small sample size, which
might have resulted in an overestimation of the relationships
found. Follow-up studies on a larger number of keratitis patients
from rural settings with high HIV prevalence are warranted to
validate the trends found in this study. Also, we included pa-
tients at the outpatient department of hospitals and not at PHC
facilities, which may have resulted in some degree of bias to-
wards viral keratitis, as potential bacterial keratitis cases were
more likely to be treated successfully at the PHC level. In addi-
tion, as we excluded patients with traumatic keratitis and contact
lens wearers, it is likely that there is some degree of bias towards
viral keratitis, as these are important predisposing factors for
microbial keratitis [2]. However, we expect the degree of this
bias to be limited, as we excluded only two keratitis cases due to
trauma and none for the use of contact lenses.
In conclusion, the results of this study implicate that her-
petic keratitis, in part complicated by bacterial superinfection
and/or uveitis, is relatively more common among HIV-
infected individuals presenting with infectious keratitis in ru-
ral South Africa. This warrants an increase of the awareness
among healthcare workers in these settings for early clinical
signs of herpetic keratitis and prompt initiation of antiviral
treatment in these cases to prevent blindness. Moreover, the
significant association between HIV infection and
keratouveitis warrants examination of the patient’s HIV status.
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